Cobalt injections into the substantia nigra of the rat: effects on behavior and dopamine metabolism in the striatum.
D015102:3,4-Dihydroxyphenylacetic Acid / Q000378:metabolism; D000818:Animals; D003035:Cobalt / Q000494:pharmacology*; D003342:Corpus Striatum / Q000187:drug effects / Q000378:metabolism*; D003913:Dextroamphetamine / Q000494:pharmacology; D004298:Dopamine / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D005968:Glutamate Decarboxylase / Q000378:metabolism; D006220:Haloperidol / Q000494:pharmacology; D006719:Homovanillic Acid / Q000378:metabolism; D008297:Male; D009043:Motor Activity / Q000187:drug effects*; D051381:Rats; D013378:Substantia Nigra / Q000187:drug effects* / Q000201:enzymology; D013997:Time Factors; D005680:gamma-Aminobutyric Acid / Q000378:metabolism
D015102:3,4-Dihydroxyphenylacetic Acid; D003035:Cobalt; D005680:gamma-Aminobutyric Acid; D005968:Glutamate Decarboxylase; D006220:Haloperidol; D003913:Dextroamphetamine; D004298:Dopamine; D006719:Homovanillic Acid